- cafead   Jan 09, 2025 at 09:32: PM
via Young biotech Dropshot Therapeutics has hooked in Etherna Immunotherapies with an RNA pact that could net up to $950 million.
The deal is intended to yield several new drug candidates across multiple undisclosed indications, according to a Jan. 9 release. Etherna will collect an undisclosed upfront payment, plus research funding, and then up to $950 million in milestone and royalty payments.
article source
The deal is intended to yield several new drug candidates across multiple undisclosed indications, according to a Jan. 9 release. Etherna will collect an undisclosed upfront payment, plus research funding, and then up to $950 million in milestone and royalty payments.
article source